Reversible Effects of Integrase Inhibitors on Newly Differentiated Adipocytes. [PDF]
Pickering RT +4 more
europepmc +1 more source
Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025. [PDF]
van Kampen J +13 more
europepmc +1 more source
Efficacy of Dolutegravir Plus Lamivudine in People With TB/HIV Co-Infection Using a Rifampicin or Rifabutin-Based Regimen: A Retrospective Observational Case Series. [PDF]
He J +7 more
europepmc +1 more source
Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue. [PDF]
Zanardo LW +8 more
europepmc +1 more source
The Epidemiology of HIV-1 Resistance to Two-Drug Regimens in Multicenter Cohort From Poland-A Cross-Sectional Study. [PDF]
Załęski A +7 more
europepmc +1 more source
Effectiveness and safety of darunavir and lopinavir for treating children and adolescents living with HIV: a systematic review. [PDF]
O'Rourke J +10 more
europepmc +1 more source
Kidney Dysfunction In Young People Living With HIV On Dolutegravir-Based Regimens In Kampala, Uganda
Nasuuna EM +4 more
europepmc +1 more source
Real-World Persistence After Starting Bictegravir- or Dolutegravir-Based Regimens Among Adults Aged ≥50 Years with HIV in the United States. [PDF]
Kong AM +9 more
europepmc +1 more source
Long-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study. [PDF]
Seong JE +10 more
europepmc +1 more source
Optimisation of Intramuscular Sustained Release-Nano-Formulations Using In Silico Modelling [PDF]
Back, D +4 more
core

